The drug Trikafta has changed the lives of many Canadians living with cystic fibrosis. But in many other parts of the world, the drug is either not available — or if it is, it costs hundreds of thousands of dollars a year. That’s why Cheri Nel, who is based in Johannesburg, is suing American pharmaceutical company Vertex over its patent and price tag.
Single parents say Canada’s policies don’t work for their families
How do you sign atom?
School boards sue social media giants
Have Canadians tuned out Justin Trudeau? We asked him
The gambling problem in sports
Saving a stranded orca calf
The affordability crisis in Canada’s North — and climate change’s role in it
How climate change is rewriting the rules of gardening
Making sense of the carbon tax
My Dad Ward: Freeing women from trafficking
Fears of water insecurity and extreme drought
Anderson Cooper on confronting grief to find the joy in life
Winnipeg is having a moment
Chocolate’s getting expensive. Is there a cheaper way to make it?
Palestinian and Israeli activists standing together for peace
Warnings ignored before Titan’s deadly dive
The woman who knows Zach Edey best — his mom
Why electric vehicles are causing sparks in politics
The problem with seeing nursing as ‘a calling’
Crisis of confidence at Boeing
Create your
podcast in
minutes
It is Free
Front Burner
Vinyl Cafe
Ideas
Someone Knows Something
Under the Influence with Terry O’Reilly